282 related articles for article (PubMed ID: 15104335)
61. Immunopathological changes in a uraemic rat model for peritoneal dialysis.
Zareie M; De Vriese AS; Hekking LH; ter Wee PM; Schalkwijk CG; Driesprong BA; Schadee-Eestermans IL; Beelen RH; Lameire N; van den Born J
Nephrol Dial Transplant; 2005 Jul; 20(7):1350-61. PubMed ID: 15840671
[TBL] [Abstract][Full Text] [Related]
62. Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model.
Mortier S; Faict D; Lameire NH; De Vriese AS
Kidney Int; 2005 Apr; 67(4):1559-65. PubMed ID: 15780112
[TBL] [Abstract][Full Text] [Related]
63. Peritoneal dialysis fluid-induced changes of the peritoneal membrane are reversible after peritoneal rest in rats.
Zareie M; Keuning ED; ter Wee PM; Beelen RH; van den Born J
Nephrol Dial Transplant; 2005 Jan; 20(1):189-93. PubMed ID: 15572385
[TBL] [Abstract][Full Text] [Related]
64. Bicarbonate buffered peritoneal dialysis fluid upregulates angiopoietin-1 and promotes vessel maturation.
Eich G; Bartosova M; Tischer C; Wlodkowski TT; Schaefer B; Pichl S; Kraewer N; Ranchin B; Vondrak K; Liebau MC; Hackert T; Schmitt CP
PLoS One; 2017; 12(12):e0189903. PubMed ID: 29253861
[TBL] [Abstract][Full Text] [Related]
65. Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo.
Zareie M; Hekking LH; Welten AG; Driesprong BA; Schadee-Eestermans IL; Faict D; Leyssens A; Schalkwijk CG; Beelen RH; ter Wee PM; van den Born J
Nephrol Dial Transplant; 2003 Dec; 18(12):2629-37. PubMed ID: 14605288
[TBL] [Abstract][Full Text] [Related]
66. Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products.
Schwenger V; Morath C; Salava A; Amann K; Seregin Y; Deppisch R; Ritz E; Bierhaus A; Nawroth PP; Zeier M
J Am Soc Nephrol; 2006 Jan; 17(1):199-207. PubMed ID: 16319192
[TBL] [Abstract][Full Text] [Related]
67. Preservation of peritoneal morphology and function by pentoxifylline in a rat model of peritoneal dialysis: molecular studies.
Hung KY; Huang JW; Chiang CK; Tsai TJ
Nephrol Dial Transplant; 2008 Dec; 23(12):3831-40. PubMed ID: 18614818
[TBL] [Abstract][Full Text] [Related]
68. The effects of ouabain and potassium on peritoneal fluid and solute transport characteristics.
Park MS; Lee EY; Lee NS; Waniewski J; Lindholm B; Lee HB
Perit Dial Int; 1998; 18(4):402-9. PubMed ID: 10505562
[TBL] [Abstract][Full Text] [Related]
69. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
[TBL] [Abstract][Full Text] [Related]
70. Tanshinone IIA attenuates peritoneal fibrosis through inhibition of fibrogenic growth factors expression in peritoneum in a peritoneal dialysis rat model.
Chunming J; Miao Z; Cheng S; Nana T; Wei Z; Dongwei C; Yuan F
Ren Fail; 2011; 33(3):355-62. PubMed ID: 21401363
[TBL] [Abstract][Full Text] [Related]
71. Biocompatible dialysis fluids for peritoneal dialysis.
Cho Y; Johnson DW; Craig JC; Strippoli GF; Badve SV; Wiggins KJ
Cochrane Database Syst Rev; 2014 Mar; (3):CD007554. PubMed ID: 24671928
[TBL] [Abstract][Full Text] [Related]
72. An amino acid-based peritoneal dialysis fluid buffered with bicarbonate versus glucose/bicarbonate and glucose/lactate solutions: an intraindividual randomized study.
Plum J; Erren C; Fieseler C; Kirchgessner J; Passlick-Deetjen J; Grabensee B
Perit Dial Int; 1999; 19(5):418-28. PubMed ID: 11379854
[TBL] [Abstract][Full Text] [Related]
73. Peritoneal transformation shortly after kidney transplantation in pediatric patients with preceding chronic peritoneal dialysis.
Zhang C; Bartosova M; Marinovic I; Schwab C; Schaefer B; Vondrak K; Ariceta G; Zaloszyc A; Ranchin B; Taylan C; Büscher R; Oh J; Mehrabi A; Schmitt CP
Nephrol Dial Transplant; 2023 Sep; 38(10):2170-2181. PubMed ID: 36754369
[TBL] [Abstract][Full Text] [Related]
74. Hyperbranched polyglycerol is superior to glucose for long-term preservation of peritoneal membrane in a rat model of chronic peritoneal dialysis.
Du C; Mendelson AA; Guan Q; Dairi G; Chafeeva I; da Roza G; Kizhakkedathu JN
J Transl Med; 2016 Dec; 14(1):338. PubMed ID: 27964722
[TBL] [Abstract][Full Text] [Related]
75. Autophagy promotes fibrosis and apoptosis in the peritoneum during long-term peritoneal dialysis.
Wu J; Xing C; Zhang L; Mao H; Chen X; Liang M; Wang F; Ren H; Cui H; Jiang A; Wang Z; Zou M; Ji Y
J Cell Mol Med; 2018 Feb; 22(2):1190-1201. PubMed ID: 29077259
[TBL] [Abstract][Full Text] [Related]
76. BMP-7 blocks mesenchymal conversion of mesothelial cells and prevents peritoneal damage induced by dialysis fluid exposure.
Loureiro J; Schilte M; Aguilera A; Albar-Vizcaíno P; Ramírez-Huesca M; Pérez-Lozano ML; González-Mateo G; Aroeira LS; Selgas R; Mendoza L; Ortiz A; Ruíz-Ortega M; van den Born J; Beelen RH; López-Cabrera M
Nephrol Dial Transplant; 2010 Apr; 25(4):1098-108. PubMed ID: 20067910
[TBL] [Abstract][Full Text] [Related]
77. Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells.
Ha H; Cha MK; Choi HN; Lee HB
Perit Dial Int; 2002; 22(2):171-7. PubMed ID: 11990400
[TBL] [Abstract][Full Text] [Related]
78. PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage.
Sandoval P; Loureiro J; González-Mateo G; Pérez-Lozano ML; Maldonado-Rodríguez A; Sánchez-Tomero JA; Mendoza L; Santamaría B; Ortiz A; Ruíz-Ortega M; Selgas R; Martín P; Sánchez-Madrid F; Aguilera A; López-Cabrera M
Lab Invest; 2010 Oct; 90(10):1517-32. PubMed ID: 20531289
[TBL] [Abstract][Full Text] [Related]
79. Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients.
Aguilera A; Yáñez-Mo M; Selgas R; Sánchez-Madrid F; López-Cabrera M
Curr Opin Investig Drugs; 2005 Mar; 6(3):262-8. PubMed ID: 15816502
[TBL] [Abstract][Full Text] [Related]
80. A chronic inflammatory infusion model of peritoneal dialysis in rats.
Margetts PJ; Kolb M; Yu L; Hoff CM; Gauldie J
Perit Dial Int; 2001; 21 Suppl 3():S368-72. PubMed ID: 11887858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
